PIGO Gene

Phosphatidylinositol Glycan Anchor Biosynthesis Class O

Gene Information Card

Symbol PIGO
Full Name Phosphatidylinositol glycan anchor biosynthesis class O
Gene Type Protein coding
Chromosomal Location 9p13.3
NCBI Gene ID 93624 ncbi.nlm.nih.gov/gene/93624
Ensembl ID ENSG00000165282
UniProt ID Q8TEQ8
OMIM ID 614730
HGNC ID 23215
Aliases FLJ00118, GPI biosynthesis class O protein

Description

The PIGO gene encodes phosphatidylinositol glycan anchor biosynthesis class O protein, a component of the glycosylphosphatidylinositol (GPI)-anchor transamidase complex. This complex is essential for attaching GPI anchors to proteins, tethering them to the cell membrane. PIGO specifically catalyzes the transfer of GPI anchors to precursor proteins in the endoplasmic reticulum. Mutations in PIGO cause hyperphosphatasia with mental retardation syndrome 2 (HPMRS2), a disorder characterized by intellectual disability, seizures, and elevated alkaline phosphatase levels.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hyperphosphatasia with mental retardation syndrome 2 (HPMRS2) Loss-of-function mutations in PIGO impair GPI anchor attachment, leading to reduced cell surface expression of GPI-anchored proteins, disrupting neuronal development and signaling. OMIM #614749; ClinVar; multiple case reports (e.g., Krawitz et al., 2012)
Intellectual disability (non-syndromic) Homozygous or compound heterozygous PIGO variants cause global developmental delay and cognitive impairment via defective GPI anchoring. ClinVar; PMID: 22985903
Seizures GPI anchor deficiency due to PIGO mutations alters synaptic protein localization, increasing neuronal excitability. OMIM; PMID: 22985903

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Liver 8.3 Low
Kidney 10.1 Medium
Testis 15.2 Medium
Lung 6.7 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 14.0 High expression in embryonic kidney cells
HeLa 9.5 Moderate expression in cervical cancer cells
K562 7.2 Low expression in leukemia cells
HepG2 8.8 Moderate expression in liver cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1462C>T (p.Arg488*) Nonsense Rare Loss of function; premature truncation of PIGO protein
c.1075G>A (p.Gly359Arg) Missense Rare Impaired GPI transamidase activity; associated with HPMRS2
c.1A>G (p.Met1?) Start loss Rare Complete loss of translation; severe phenotype
Mutation functional classification

Loss of Function (LOF)

Most PIGO mutations are loss-of-function, reducing or abolishing GPI anchor attachment, leading to HPMRS2.

Gain of Function (GOF)

No gain-of-function mutations reported for PIGO.

Dominant Negative (DN)

No dominant-negative mutations reported; inheritance is autosomal recessive.

Gene Ontology (GO)

• GPI anchor biosynthetic process • GPI-anchor transamidase activity
• endoplasmic reticulum membrane • integral component of membrane
• protein glycosylation

Pathways

Glycosylphosphatidylinositol (GPI)-anchor biosynthesis (KEGG: hsa00563)
GPI-anchor transamidation (Reactome: R-HSA-162791)

Protein Summary

PIGO is a 1,089-amino acid transmembrane protein localized to the endoplasmic reticulum membrane. It functions as the catalytic subunit of the GPI transamidase complex, cleaving a C-terminal signal peptide from precursor proteins and attaching a pre-assembled GPI anchor. The protein contains a conserved catalytic cysteine residue essential for transamidation. Defects in PIGO disrupt GPI anchoring, leading to loss of cell surface proteins such as alkaline phosphatase and neural adhesion molecules.

Related Products

Product name Cat.No. Species Gene ID
PIGO Knockout HEK293 Cell Line EDJ-KQ218 Human 84720 Details Get a Quote
PIGO Knockout HCT 116 Cell Line EDJ-KQ36061 Human 84720 Details Get a Quote
PIGO Knockout A-549 Cell Line EDJ-KQ37299 Human 84720 Details Get a Quote
PIGO Knockout HeLa Cell Line EDJ-KQ37301 Human 84720 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: